Page last updated: 2024-10-18

glycine and Neoplasms, Plasma Cell

glycine has been researched along with Neoplasms, Plasma Cell in 1 studies

Neoplasms, Plasma Cell: Neoplasms associated with a proliferation of a single clone of PLASMA CELLS and characterized by the secretion of PARAPROTEINS.

Research Excerpts

ExcerptRelevanceReference
"Both cell line-derived OCI-Ly10 and primary human lymphoma-derived PHTX22L xenograft models of diffuse large B-cell lymphoma were used to evaluate the pharmacodynamics and antitumor effects of MLN2238 and bortezomib."3.77Antitumor activity of the investigational proteasome inhibitor MLN9708 in mouse models of B-cell and plasma cell malignancies. ( Bannerman, B; Bano, K; Berger, AJ; Bolen, JB; Bradley, DP; Carsillo, M; Donelan, J; Fitzgerald, M; Hales, P; Janz, S; Kupperman, E; Lee, EC; Li, P; Li, Z; Liu, R; Manfredi, M; Neppalli, VT; Pickard, M; Silva, MD; Subakan, O; Tayber, O; Terkelsen, J; Van Ness, B, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, EC1
Fitzgerald, M1
Bannerman, B1
Donelan, J1
Bano, K1
Terkelsen, J1
Bradley, DP1
Subakan, O1
Silva, MD1
Liu, R1
Pickard, M1
Li, Z1
Tayber, O1
Li, P1
Hales, P1
Carsillo, M1
Neppalli, VT1
Berger, AJ1
Kupperman, E1
Manfredi, M1
Bolen, JB1
Van Ness, B1
Janz, S1

Other Studies

1 other study available for glycine and Neoplasms, Plasma Cell

ArticleYear
Antitumor activity of the investigational proteasome inhibitor MLN9708 in mouse models of B-cell and plasma cell malignancies.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Dec-01, Volume: 17, Issue:23

    Topics: Animals; Antineoplastic Agents; Boron Compounds; Boronic Acids; Bortezomib; Cell Line, Tumor; Glycin

2011